Name: Dyslipidemia (en Inglés)
Price: 585.74 PEN
Availability: InStock
Author: McFarlane, Samy I.
ISBN: 9781839680038

Formato

Libro Físico

Editorial

Intechopen

Autor

McFarlane, Samy I.

Idioma

Inglés

N° páginas

182

Encuadernación

Tapa Dura

Dimensiones

24.4 x 17.0 x 1.1 cm

Peso

0.49 kg.

ISBN13

9781839680038

Categorías

Enfermedades cardiovasculares

Dyslipidemia (en Inglés)

Mcfarlane, Samy I. (Autor) · Intechopen · Tapa Dura

Libro Nuevo

S/ 585,74

S/ 1.171,47

Ahorras: S/ 585,74

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 26 de Julio y el Martes 06 de Agosto.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Dyslipidemia (en Inglés)"

Dyslipidemia is a major risk factor for cardiovascular disease, which is the leading cause of morbidity and mortality around the globe, particularly among aging populations. Lipoprotein disorders, frequently encountered by clinicians, require early recognition and treatment. In this book, we assembled a group of world-renowned scholars in their field to address major areas in lipoprotein disorders that are imminently relevant to clinicians and other healthcare providers. Areas discussed include an overview of lipid metabolism, a complex topic, presented in a simplified and rational way. We also highlight recent developments in the field including dyslipidemias characterized by nontraditional lipid biomarkers. Furthermore, we discuss the pathogenesis of atherosclerosis and the role of dyslipidemia. Other chapters include the assessment of primary and secondary causes of dyslipidemia. Targets for treatment as well as the role of major therapeutic agents including statins and PCSK9 inhibitors are also discussed in light of the most recent guidelines by major international organizations. This is in addition to an overview of lifestyle and dietary modification as well as alternative options for dyslipidemia management. Furthermore, dyslipidemia in special populations is emphasized including various ethnic groups as well as those with HIV disease, chronic kidney disease, among others. The role of adiposity including brown fat together with highlights on lipidomics and dyslipidemias characterized by nontraditional lipid biomarkers is also highlighted. We believe that this volume will serve as a valuable resource, not only for clinicians and other healthcare providers, but for students and research scholars as well.